Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2003
02/27/2003CA2456988A1 Gas microsphere liposome composites
02/27/2003CA2456985A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003CA2456983A1 Adjuvant chemotherapy for anaplastic gliomas
02/27/2003CA2456976A1 Expandable gastric retention device
02/27/2003CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/27/2003CA2456868A1 Inhibitors of polyq-aggregation
02/27/2003CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors
02/27/2003CA2456820A1 Physiological method of improving vision
02/27/2003CA2456746A1 Method for treating lung cancers
02/27/2003CA2456743A1 Tocopherol enriched compositions and amelioration of inflammatory symptoms
02/27/2003CA2456725A1 Chemo-enzymatic synthesis of sialylated oligosaccharides
02/27/2003CA2456551A1 Tumour inhibiting lanthanum compounds
02/27/2003CA2456477A1 Antimicrobial cationic peptides and formulations thereof
02/27/2003CA2456292A1 Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog
02/27/2003CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides
02/27/2003CA2456206A1 Sodium salt of an hiv integrase inhibitor
02/27/2003CA2456150A1 Selective estrogen receptor modulators
02/27/2003CA2456149A1 Recombinant conjugate polypeptides for photodynamic therapy
02/27/2003CA2455974A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution
02/27/2003CA2454762A1 Isoxazolopyridinones
02/27/2003CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone
02/27/2003CA2454298A1 Substituted 1h-dihydropyrazoles, their preparation and use
02/27/2003CA2454083A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
02/27/2003CA2453962A1 Diazacycloalkanes as oxytocin agonists
02/27/2003CA2453647A1 1-alkyl 0r 1-cycloalkyltriazolo¬4,3-a|quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003CA2452801A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
02/27/2003CA2423025A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels
02/26/2003WO2002020010A1 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
02/26/2003WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1
02/26/2003EP1285960A2 Virulence genes from Salmonella typhimurium
02/26/2003EP1285947A1 Antimicrobial composition
02/26/2003EP1285927A2 Use of glucocorticoid antagonists for the prevention and treatment of diseases of the male reproductive system
02/26/2003EP1285922A1 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/26/2003EP1285920A1 C10 Ester sustituted taxanes as antitumor agents
02/26/2003EP1285919A1 C10 Carbonate substituted taxanes as antitumor agents
02/26/2003EP1285918A1 C7 Ester substituted taxanes as antitumor agents
02/26/2003EP1285917A1 Process for producing carbostyril derivative
02/26/2003EP1285916A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNF alpha levels
02/26/2003EP1285914A1 Nr1h4 nuclear receptor binding compounds
02/26/2003EP1285672A1 Prefilled injector package and sterilizing or disinfecting method therefor.
02/26/2003EP1285667A2 Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
02/26/2003EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions
02/26/2003EP1285660A1 Zinc-supplementary compositions for oral administration
02/26/2003EP1285659A1 Use of clarithromycin compositions in the manufacture of a medicament for the treatment of arthritis deformans
02/26/2003EP1285658A2 Treatments for female sexual dysfunction
02/26/2003EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
02/26/2003EP1285656A1 Acetylcholinesterase inhibitors containing 1-benzyl- pyridinium salts
02/26/2003EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers
02/26/2003EP1285654A1 Autonomic controlling agents and health drinks and foods
02/26/2003EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence
02/26/2003EP1285652A1 Novel fatty acid analogues for the treatment of hypertension
02/26/2003EP1285650A1 Method and compositions for inhibiting arteriosclerosis
02/26/2003EP1285649A1 Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers
02/26/2003EP1285590A1 Lipid blends
02/26/2003EP1285087A2 Enzymatic assays for screening anti-cancer agents
02/26/2003EP1285081A2 Improved methods of transfection
02/26/2003EP1285061A1 Antisense modulation of pten expression
02/26/2003EP1285058A2 Fertilization of aged oocytes
02/26/2003EP1285002A2 REGULATING LIPID LEVELS VIA THE i ZMAX1 /i OR i HBM /i GENE
02/26/2003EP1284992A2 Polyubiquitin based hydrogel and uses thereof
02/26/2003EP1284984A1 Uridine derivatives as antibiotics
02/26/2003EP1284977A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
02/26/2003EP1284976A2 Diazabicyclic central nervous system active agents
02/26/2003EP1284974A2 Triazolyl tropane derivatives as ccr5 modulators
02/26/2003EP1284973A2 Inhibitors of alpha l beta 2 mediated cell adhesion
02/26/2003EP1284967A1 3-substituted isoquinolin-1-yl derivatives
02/26/2003EP1284963A1 Novel calcium receptor active molecules and method for preparing same
02/26/2003EP1284961A1 Glycinamides
02/26/2003EP1284960A1 Cyclic amino acid derivatives useful as pharmaceutical agents
02/26/2003EP1284959A1 Compounds for modulating the rage receptor
02/26/2003EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
02/26/2003EP1284956A1 Il-8 receptor antagonists
02/26/2003EP1284952A1 Substituted chalcones as therapeutic compounds
02/26/2003EP1284771A1 Aerosol container for formulations of salmeterol xinafoate
02/26/2003EP1284754A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
02/26/2003EP1284753A2 Combination of growth hormone secretagogues and antidepressants
02/26/2003EP1284750A1 Pharmaceutical composition
02/26/2003EP1284749A2 Use of hyaluronidase for preventing and treating cardio vascular diseases
02/26/2003EP1284743A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
02/26/2003EP1284742A2 Biological joint lubricant composition and method of applying
02/26/2003EP1284741A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
02/26/2003EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds
02/26/2003EP1284739A1 Composition and method for intervening neuronal death using sulfasalazine
02/26/2003EP1284738A1 (+) naloxone and epinephrine combination therapy
02/26/2003EP1284737A1 Water soluble prodrugs of azole compounds
02/26/2003EP1284736A2 Opioid antagonist compositions and dosage forms
02/26/2003EP1284735A1 Apomorphine derivatives and methods for their use
02/26/2003EP1284734A1 Protein kinase inhibitors
02/26/2003EP1284733A1 Novel processes for preparing torsemide intermediate
02/26/2003EP1284732A2 Method for treating functional dyspepsia using alosetron
02/26/2003EP1284731A1 Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP1284729A1 A(beta)42 lowering agents
02/26/2003EP1284728A1 Pharmaceuticals for treating obesity
02/26/2003EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease
02/26/2003EP1284726A1 Method of chlamydia prophylaxis
02/26/2003EP1284725A2 Medicament for the treatment of diseases caused by parasitic protozoa
02/26/2003EP1284723A1 Compositions and therapies for hyperlipidaemia-associated disorders
02/26/2003EP1284722A2 Compositions containing a benzamide disulfide derivative for treating allergic diseases
02/26/2003EP1284721A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
1 ... 5552 5553 5554 5555 5556 5557 5558 5559 5560 5561 5562 5563 5564 5565 5566 5567 5568 5569 5570 5571 5572 ... 7860